// App-Quantinova.ai

2250 : Genetic and Environmental Risk Factors in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Researchers

Presenter

  • Austin Wheeler

Principal Investigators

  • Yangyuna Yang

  • Joshua Baker

  • Jill Poole

  • Dana Ascherman

  • Gail Kerr

  • Andreas Reimold

  • Gary Kunkel

  • Grant Cannon

  • Katherine Wysham

  • Namrata Singh

  • Deana Lazaro

  • Paul Monach

  • S. Louis Bridges, Jr

  • Ted Mikuls

  • Bryant England

Medical Centers

  • University of Nebraska Medical Center, Omaha, NE

  • University of Pennsylvania, Philadelphia, PA

  • University of Pittsburgh, Pittsburgh, PA

  • Washington DC VA Medical Center, Georgetown and Howard Universities, Washington DC, DC

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • University of Utah, Salt Lake City, UT

  • Retired, Salt Lake City, UT

  • VA-Puget Sound/University of Washington, Seattle, WA

  • University of Washington, Seattle, WA

  • VA New York Harbor Healthcare system, Short Hills, NJ

  • VA Boston Healthcare System, Boston, MA

  • Hospital for Special Surgery, New York, NY.

  • Division of Radiology, University of Nebraska Medical Center, Omaha, NE

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A